RESEARCHER PROFILE
Aya M. Serry
← Back to Modern University for Information and Technology
A
Modern University for Information and Technology
Aya M. Serry works in Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds, Synthesis of Organic Compounds, Bioactive natural compounds, Natural Antidiabetic Agents Studies. Recorded institutional associations include Modern University for Information and Technology.
12Publications
224Citations
8H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Synthesis and molecular docking study of new benzofuran and furo[3,2- g ]chromone-based cytotoxic agents against breast cancer and p38α MAP kinase inhibitors
2018 · 67 citationsAngiokinase inhibition of VEGFR-2, PDGFR and FGFR and cell growth inhibition in lung cancer: Design, synthesis, biological evaluation and molecular docking of novel azaheterocyclic coumarin derivatives
2021 · 43 citationsSynthesis and molecular docking studies of new furochromone derivatives as p38α MAPK inhibitors targeting human breast cancer MCF-7 cells
2017 · 26 citationsAntitumor and multikinase inhibition activities of some synthesized coumarin and benzofuran derivatives
2022 · 24 citationsOne-Pot Synthesis of 4,6-Diaryl-2-oxo(imino)-1,2-dihydropyridine-3-carbonitrile; a New Scaffold for p38α MAP Kinase Inhibition
2010 · 22 citationsIn vitro and in vivo antidiabetic evaluation of new Coumarin and Chromone derivatives: Design, synthesis and molecular modeling
2025 · 14 citationsDesign, synthesis and molecular docking studies of tailored coumarin and chromone derivatives for use as anti-Alzheimer agents
2024 · 10 citationsAn overview of pyridazin-3(2 H )-one: a core for developing bioactive agents targeting cardiovascular diseases and cancer
2024 · 9 citationsDesign, synthesis, and biological evaluation of some new 2-phenyl-3,6-pyridazinedione derivatives as PDE-5 inhibitors
2024 · 4 citationsBiosynthesis and Characterization of Aeonium arboreum-Derived Silver Nanoparticles: Antimicrobial Activity, Biofilm Inhibition, Antihemolytic Activity, and In Silico Studies
2024 · 4 citationsEffect of Phenolics from Aeonium arboreum on Alpha Glucosidase, Pancreatic Lipase, and Oxidative Stress; a Bio-Guided Approach
2023 · 2 citations
